A Systems-Biology Framework for Non-Linear Disease Progression, Endothelial Instability, and Biological Conditioning
Description
This document presents a speculative, conceptual framework, not a validated scientific result. The model has not been fitted to clinical data, tested against patient outcomes, or empirically validated. The accompanying simulation is illustrative: it demonstrates the qualitative behavior of the proposed equations under chosen parameters; it is not evidence that biological systems behave as described. The biomarkers, mechanisms, and clinical phenomena referenced — IL-6 signaling, endothelial dysfunction, Immune Reconstitution Inflammatory Syndrome, and others — are real and well-documented, but their integration into the unified structure proposed here is exploratory. The central aim is to ask whether disease progression might be productively modeled as a problem of dynamical-systems stability and proximity to a critical threshold, rather than as linear accumulation of damage alone. Nothing here should inform medical decision-making. 1. Motivation Chronic disease has traditionally been modeled within linear frameworks, where physiological decline is understood as the gradual accumulation of molecular and cellular damage. Yet across oncology, cardiology, neurology, and infectious disease, clinical trajectories frequently show abrupt, disproportionate deterioration after periods of apparent stability. These discontinuities suggest that progression may not be primarily linear, but governed by nonlinear dynamics in which system stability — rather than cumulative burden alone — determines outcome. This framework proposes that the organism behaves as a coupled nonlinear system of immune activation, inflammatory signaling, and endothelial regulation, and that disease emerges when this system is driven past a stability boundary rather than worn down gradually.